EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current State of Clinical Care of People With Cystic Fibrosis

Cameron J McKinzie iD, Charissa W Kam iD, Paul M Beringer iD, Brittany A Wright iD, Wendy M Bullington iD, Sabrina Garcia iD, Jonathan J Grant, Rebecca S Pettit iD, David C Young iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-04 · 46 (4)

DOI: 10.1002/phar.70138 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 15.03.2026. Verfasst von Cameron J McKinzie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit nennt 116 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advent of cystic fibrosis transmembrane conductance regulator (CFTR) modulators has dramatically changed the landscape of the clinical care of people with cystic fibrosis (PwCF). In particular, highly effective modulator therapy (HEMT) availability for the majority of PwCF has led to changes in pharmacotherapy regimens and clinical outcomes but has also been associated with adverse effects and drug interactions. The role of CFTR modulator therapy perinatally continues to be of great interest, related to both the mother with CF as well as the infant in utero and after birth. As the median life expectancy for PwCF continues to increase, consideration must also be given for treatment of cardiovascular disease and other comorbidities as well as cancer screening and other preventative care measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansFemaleDrug Interactions

Stichwörter der Autor:innen

cystic fibrosiscystic fibrosis transmembrane conductance regulatorpulmonology

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
  • Alred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, USA.
  • University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA.
  • Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Pharmacy, St. Luke's Medical Center, Boise, Idaho, USA.
  • Department of Outpatient Pharmacy - Specialty Services, Johns Hopkins Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Cameron J McKinzie, Charissa W Kam, Paul M Beringer, Brittany A Wright, Wendy M Bullington, Sabrina Garcia, Rebecca S Pettit, David C Young

Zitieren

APA

McKinzie, C. J., Kam, C. W., Beringer, P. M., Wright, B. A., Bullington, W. M., Garcia, S., Grant, J. J., Pettit, R. S., & Young, D. C. (2026). Current State of Clinical Care of People With Cystic Fibrosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(4). https://doi.org/10.1002/phar.70138

Vancouver

McKinzie CJ, Kam CW, Beringer PM, Wright BA, Bullington WM, Garcia S, et al. Current State of Clinical Care of People With Cystic Fibrosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(4). doi:10.1002/phar.70138

BibTeX
@article{McKinzie2026,
  author = {McKinzie, Cameron J and Kam, Charissa W and Beringer, Paul M and Wright, Brittany A and Bullington, Wendy M and Garcia, Sabrina and Grant, Jonathan J and Pettit, Rebecca S and Young, David C},
  title = {Current State of Clinical Care of People With Cystic Fibrosis},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1002/phar.70138}
}
Kostenlos starten →